NVO

Novo-Nordisk A/S
D

NVO

Arincen60/100B

Novo-Nordisk A financials

Yes. Novo-Nordisk A/S earned 113.07B DKK of net income over the last twelve months, 33.9% of its revenue. It made a profit in 41 of its 41 fiscal years since 1985.

Revenue (TTM)
333.14B DKK
Net income (TTM)
113.07B DKK
Free cash flow (TTM)
46.32B DKK
Cash and short-term investments
49.18B DKK
Total debt
134.48B DKK
Shareholders' equity
217.80B DKK

Cash, debt and equity as of 30 Sept 2026.

Novo-Nordisk A earnings

Next earnings · Q4 FY2026
EPS estimate
0.68 USD
Revenue estimate
11.78B USD
Last quarter · Q3 FY2026
EPS0.89Beat +21.8%Revenue11.90BBeat +7.5%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q4 FY20260.68——-32.00%11.78B——-5.75%
Q3 FY20260.730.89+21.75%-12.75%11.07B11.90B+7.54%+3.25%
Q2 FY20260.820.96+17.07%-1.03%10.89B12.13B+11.40%+1.30%
Q1 FY20260.871.04+19.54%+13.04%10.86B11.02B+1.50%-7.35%
Q4 FY20250.901.00+11.11%+9.89%12.13B12.50B+3.10%+5.44%
Q3 FY20250.771.02+32.47%+15.91%11.94B11.53B-3.47%+7.93%
Q2 FY20250.930.97+4.30%+47.64%11.92B11.97B+0.43%+22.19%

Novo-Nordisk A growth and profitability

Full income statement
Revenue (TTM)
333.14B DKK
Net income (TTM)
113.07B DKK
Gross margin
82.01%
Operating margin
46.15%
Net margin
33.94%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY2025309.06B+6.43%102.43B+1.43%80.98%41.30%33.14%156.73B+5.94%
FY2024290.40B+25.03%100.99B+20.68%84.67%44.19%34.78%147.94B+29.06%
FY2023232.26B+31.26%83.68B+50.71%84.60%44.16%36.03%114.63B+49.25%
FY2022176.95B+25.68%55.53B+16.27%83.92%42.28%31.38%76.80B+17.45%
FY2021140.80B+10.91%47.76B+13.33%83.20%41.65%33.92%65.39B+10.33%

How Novo-Nordisk A makes its money

Revenue309.06B 100.0%
Cost of revenue58.79B 19.0%
Gross profit250.28B 81.0%
Research and development52.04B 16.8%
Selling and administration70.28B 22.7%
Other operating expenses300.00M 0.1%
Operating income127.66B 41.3%
Tax28.11B 9.1%
Net income102.43B 33.1%

FY2025, in DKK. Each band is as wide as its money; the percentage is its share of revenue.

Novo-Nordisk A revenue breakdown

By region

FY2023
North America: 63.4%EMEA: 23.6%Rest of World: 13.0%63.4%North America23.6%EMEA13.0%Rest of World
RegionRevenueShare of revenueChange on the year
North America136.63B63.4%+50.0%
EMEA50.87B23.6%+15.0%
Rest of World28.08B13.0%+10.5%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY2025119.10B28.99B
FY2024120.97B69.66B
FY2023108.91B70.01B
FY202278.89B64.13B
FY202155.00B47.62B
FY202051.95B29.87B
FY201946.78B35.55B
FY201844.62B32.21B
FY201741.17B32.52B
FY201648.31B40.05B

Novo-Nordisk A financial health

Full balance sheet
Cash and short-term investments
49.18B DKK
Total debt
134.48B DKK
Net cash
-85.30B DKK
Free cash flow (TTM)
46.32B DKK
Current ratio
0.84
Debt to equity
0.62
Piotroski score
7 / 9
Altman Z-score
3.74

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY202526.96B130.96B28.99B
FY202426.31B102.79B69.66B
FY202330.23B27.01B70.01B
FY202223.57B25.78B64.13B
FY202117.49B26.65B47.62B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY2025542.90B348.86B194.05B
FY2024465.80B322.31B143.49B
FY2023314.49B207.93B106.56B
FY2022241.26B157.77B83.49B
FY2021194.51B123.76B70.75B
FY2020144.92B81.60B63.33B
FY2019125.61B68.02B57.59B
FY2018110.77B58.93B51.84B
FY2017102.36B52.54B49.82B
FY201697.54B52.27B45.27B

Novo-Nordisk A valuation

Price to earnings ratio (TTM)
10.89
Forward P/E (FY2026)
12.09
Price to sales (TTM)
3.67
Price to book
5.61
EV / EBITDA (TTM)
7.07

Capital structure

Market capitalization
180.72B USD
+
Total debt
19.88B USD
−
Cash and short-term investments
7.27B USD
=
Enterprise value
193.33B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)11.34————
FY2027 (est.)12.2611.34———
FY2026 (est.)12.0912.26———
Now (TTM)10.8912.243.675.617.07
FY202514.0314.124.667.429.85
FY202427.3326.339.5019.2319.24
FY202337.4130.9813.4829.3827.43
FY202238.3525.9612.0325.5027.90
FY202135.22—11.9423.7725.96

Novo-Nordisk A against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Pfizer, Gilead Sciences, Bristol-Myers Squibb, Amgen, Merck & Co., and AbbVie, the US Drug Manufacturers - General companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Below its median10.9
    9.350.6
  • Gross marginLowest in 5 years81.0%
    81.0%84.7%
    Against its peers: 1 of 7Peers' median 71.5%
  • Operating marginLowest in 5 years41.3%
    41.3%44.2%
    Against its peers: 1 of 7Peers' median 31.0%
  • Net marginBelow its median33.1%
    31.4%36.0%
    Against its peers: 1 of 7Peers' median 17.8%
  • Return on equityLowest in 5 years52.8%
    52.8%78.5%
    Against its peers: 2 of 6Peers' median 37.5%
  • Free cash flow marginLowest in 5 years9.4%
    9.4%36.2%
    Against its peers: 7 of 7Peers' median 24.3%
  • Revenue growthLowest in 5 years6.4%
    6.4%31.3%
    Against its peers: 3 of 7Peers' median 1.8%
  • EPS growthLowest in 5 years1.8%
    1.8%52.4%
    Against its peers: 4 of 6Peers' median 8.0%
  • Debt to EBITDAHighest in 5 years0.84×
    0.24×0.84×
    Against its peers: 1 of 7Peers' median 3.16×
  • Current ratioBelow its median0.80
    0.740.89
    Against its peers: 6 of 7Peers' median 1.21

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Novo-Nordisk A dividends

Annual dividend
1.16 USD
Dividend yield (indicated)
2.83%
Payout ratio
47.72%
Frequency
Semi-annual
Last payment
0.58 USD
Last ex-dividend date
17 Aug 2026
Last payment date
25 Aug 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share1.731.451.030.800.740.650.610.630.570.71

Novo-Nordisk A ownership

Institutions
7.41%
Institutional holders
1,456 (+84)
Free float
71.58%

Who owns the shares

Institutions 7.4% Others 92.6%
As of 30 Jun 2026

Shares free to trade

Free float 3.16B shares ·71.6% Closely held 1.25B shares ·28.4%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY20254.45B4.45B-0.34%
FY20244.45B4.46B-0.71%
FY20234.48B4.49B-1.10%
FY20224.53B4.54B-1.34%
FY20214.59B4.61B-1.58%

Common questions about Novo-Nordisk A's financials

Source: Financial Modeling PrepVerified against SEC filings